(5/11/2012)		Three Perspectives on the Impact of CER on Decision Making

(4/2/2012)		Pharmaceutical Technology Assessment--Perspectives From Payers

(3/27/2012)		CER and the Environment for Decision Making 2012

(2/24/2012)		Making Informed Decisions-Assessing Strengths and Weaknesses of CER Study Designs

(12/28/2011)		2011 NPC Annual Report

(12/5/2011)		Setting Priorities for CER-From Assessing Public Health Benefits to Being Open With the Public

(7/10/2011)		CER: Do Employers Care-What Will They Do-JOEM

(6/28/2011)		Blue Pill or Red Pill-The Limits of Comparative Effectiveness Research

(6/28/2011)		The Impact of CER on Health and Health Care Spending

(6/21/2011)		CER-Do Employers Care-What Will They Do

(6/10/2011)		Medication Adherence, Comorbidities, and Health Risk Impacts on Workforce Productivity

(6/10/2011)		The Productivity Crisis in Pharmaceutical Research and Development

(4/25/2011)		Comparative Effectiveness Research Stakeholder Survey

(2/27/2011)		Synergies at Work: Realizing the Full Value of Health Investment

(1/28/2011)		PCORI Methodology Committee Resource Guide

(10/1/2010)		International Comparison of CER in Five Jurisdictions: Insights for the U.S.

(9/27/2010)		The Patient-Centered Outcomes Research Institute Resource Guide

(7/13/2010)		Value in Health - Apples and Oranges: Assessing CER

(6/24/2010)		Comparative Effectiveness Research Toolkit

(6/24/2010)		VBID Toolkit

(5/1/2010)		Comparative Effectiveness Informational Series

(4/15/2010)		GRACE Principles

(11/30/2009)		Demystifying CER: A Case Study Learning Guide - Executive Summary

(11/30/2009)		Demystifying Comparative Effectiveness Research: A Case Study Learning Guide

(11/17/2009)		Employer Medication Compliance Initiatives

(11/17/2009)		Framing the Debate-Untangling the Impact of CER on Innovation

(11/1/2009)		Health Plan Capabilities to Support Value Based Benefit Design

(9/15/2009)		Resources for Medicare Beneficiaries: Using Your Medicare Drug Plan - What to Do if Your Medicine

(9/10/2009)		Your Pharmacy Benefit: Make it Work for You!

(7/20/2009)		About NPC Brochure

(7/13/2009)		Value-Based Insurance Design Landscape Digest

(7/1/2009)		Future Costs, Risks and Rewards of Drug Development

(6/28/2009)		What Evidence Do Payers Need

(4/13/2009)		Health and Productivity as a Business Strategy: A Multiemployer Study - 2009

(8/1/2008)		Frequent Users of Health Services

(7/1/2008)		Does the Work of NICE Have Relevance for the US?

(6/1/2008)		Pharmaceutical Benefit Design: Helping Employers Understand, Assess, Select and Manage Pharmacy

(5/1/2008)		NICE: How Does It Work and Implications for US - Executive Summary

(5/1/2008)		Resources for Medicare Beneficiaries: Navigating the Coverage Gap - How the Gap May Affect You

(5/1/2008)		NICE: How Does It Work and Implications for the US

(4/1/2008)		Current Evidence-Based Medicine Landscape

(1/1/2008)		Improving and Measuring Osteoporosis Management

(7/1/2007)		Health and Productivity as a Business Strategy - A Multi-Employer Research Study

(1/1/2007)		Pharmaceutical Benefits Under State Medical Assistance Programs, 2007

(12/1/2006)		State Medicaid Resource Kit: Maintaining Quality and Patient Access to Innovative Pharmaceuticals in

(8/1/2006)		A History of Creating the Medicare Prescription Drug Benefit

(7/20/2006)		Urinary Incontinence: Economic Burden and New Choices in Pharmaceutical Treatment

(7/1/2006)		Medicare Drug Benefit: Impact on States and Cost Containment

(5/16/2006)		Fraction of Nursing Home Admissions Attributable to Urinary Incontinence

(5/1/2006)		Clinical and Economic Advantages of Modern Dosage Forms: Improving Medication Adherence

(4/1/2006)		Follow the Dollar: Understanding Drug Prices and Beneficiary Costs Under Medicare Part D

(1/10/2006)		National Health Spending in 2004: Recent Slowdown Led By Prescription Drug Spending

(11/15/2005)		Drug Delivery Systems Improve Pharmaceutical Profile and Facilitate Medication Adherence

(11/1/2005)		Drug Delivery Systems Improve Pharmaceutical Profile and Facilitate Medication Adherence

(11/1/2005)		Value of Investment in Health Care: Better Care, Better Lives - Executive Summary

(4/1/2005)		Impact on States of Medicare Drug Benefit: Information for State Legislators

(4/1/2005)		Availability of New Drugs and Americans' Ability to Work

(4/1/2005)		Impact on States of the Medicare Drug Benefit: Information for State Administrators

(2/15/2005)		Ten Things You Need to Know about Medicare's New Prescription Drug Coverage

(1/1/2005)		Ethnic Disparities in the Burden and Treatment of Asthma

(1/1/2005)		Pharmaceutical Benefits Under State Medical Assistance Programs, 2005

(1/1/2005)		Ten Things You Need to Know about Medicare's New Prescription Drug Coverage

(10/1/2004)		Genes, Culture, and Medicines: Bridging Gaps in Treatment for Hispanic Americans

(10/1/2004)		Disease Management for Diabetes

(10/1/2004)		Presenteeism: At Work--But Out of It

(9/1/2004)		Toward Individualized Pharmaceutical Care of East Asians

(4/1/2004)		Health, Absence, Disability, and Presenteeism: Cost Estimates of Certain Physical and Mental Health

(1/1/2004)		Disease Management for Asthma

(1/1/2004)		Pharmaceutical Benefits Under State Medical Assistance Programs, 2004

(1/1/2004)		Disease Management for Heart Failure

(1/1/2004)		Disease Management for Schizophrenia

(1/1/2004)		Value of Investment in Health Care - Better Care, Better Lives

(6/10/2003)		Pharmaceuticals and Worker Productivity Loss: A Critical Review of the Literature

(6/1/2003)		Medicaid Disease Management Programs: Findings from Three Leading U.S. State Programs

(3/15/2003)		Breathing Easier: Messages for Asthma Relief

(3/15/2003)		1953-2003: A Historical Retrospective of NPC

(3/15/2003)		Agitation and Depression in Frail Nursing Home Elderly Patients with Dementia

(3/1/2003)		Improving the Quality of Pain Management Through Measurement and Action

(2/23/2003)		Consumers’ Reports on the Health Effects of Direct-To-Consumer Drug Advertising

(2/12/2003)		Public Health Impact of Direct-To-Consumer Advertising of Prescription Drugs

(1/1/2003)		Impact of Tiered Co-Pays: A Survey of Patients and Pharmacists

(1/1/2003)		Disease Management for Depression

(1/1/2003)		Disease Management for Chronic Obstructive Pulmonary Disease

(1/1/2003)		Finding Arthritis Strategies that Work

(1/1/2003)		Pharmaceutical Benefits Under State Medical Assistance Programs, 2003

(1/1/2003)		State Medicaid Program Issues: Preferred Drug Lists, 2003

(1/1/2003)		Overview of Two Monographs on Pain Management

(1/1/2003)		Living Right: Tips for the Ticker

(10/15/2002)		Measuring the Costs and Benefits of Pharmaceutical Expenditures

(10/1/2002)		Racial and Ethnic Differences in Response to Medicines: Towards Individualized Pharmaceutical Treatm

(10/1/2002)		A Closer Look at Depression

(10/1/2002)		Growth in Use of Lipid-Lowering Therapies: Are We Targeting the Right Patients?

(10/1/2002)		Cultural and Genetic Diversity in America: The Need for Individualized Pharmaceutical Treatment

(10/1/2002)		A Closer Look at Diabetes

(10/1/2002)		A Closer Look at High Blood Pressure

(5/1/2002)		Pharmaceutical Diversity Serves Human Diversity: Medications for Older Adults

(5/1/2002)		Pharmaceuticals for Elders: Why Innovation Matters

(5/1/2002)		Genetic Variations in Response to Medications: Looking at the Implications for Minority Elders

(3/15/2002)		Costs and Benefits of Pharmaceuticals: The Value Equation for Older Americans

(1/1/2002)		A Closer Look at Arthritis

View all